Skip to main content
. 2019 May 25;25:3894–3901. doi: 10.12659/MSM.913556

Figure 2.

Figure 2

The RFS of all patients (A), early clinical stage patients (B), and clinical advanced stage patients (C) high expression of TRMT6 group and low expression of TRMT6 group.